From the Food and Drug Administration.
Nightingale
S L
SL
D003587:Cytomegalovirus / Q000276:immunology*; D004618:Embolism, Air / Q000209:etiology*; D005260:Female; D015483:HIV Antibodies / Q000032:analysis*; D015498:HIV-2 / Q000276:immunology; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D053685:Laser Therapy / Q000009:adverse effects*; D011933:Reagent Kits, Diagnostic; D012151:Resuscitation; D014481:United States; D014486:United States Food and Drug Administration; D014599:Uterus / Q000601:surgery
D015483:HIV Antibodies; D007106:Immune Sera; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D011933:Reagent Kits, Diagnostic; C045781:cytomegalovirus-specific hyperimmune globulin